Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer.
about
Molecular Interactions of β-(1→3)-Glucans with Their ReceptorsAn evidence-based review of a Lentinula edodes mushroom extract as complementary therapy in the surgical oncology patientInhibiting complement regulators in cancer immunotherapy with bispecific mAbs.Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancerCombined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways.Yeast-derived beta-glucan augments the therapeutic efficacy mediated by anti-vascular endothelial growth factor monoclonal antibody in human carcinoma xenograft models.A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy.Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivityCombined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy.Beta-glucans as immunostimulant in vertebrates and invertebrates.Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1.Placebo-driven clinical trials of yeast-derived β-(1-3) glucan in children with chronic respiratory problemsβ-Glucans inhibit intracellular growth of Mycobacterium bovis BCG but not virulent Mycobacterium tuberculosis in human macrophages.beta-glucan from Saccharomyces cerevisiae as a blood platelet antioxidant.Effects of yeast-derived beta-glucans on blood cholesterol and macrophage functionality.Gamma-irradiated β-glucan modulates signaling molecular targets of hepatocellular carcinoma in rats.Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer.Candida albicans β-glucan-containing particles increase HO-1 expression in oral keratinocytes via ROS/p38MAPK/Nrf2 pathway.
P2860
Q26859196-42FCBCD8-4C47-4FDF-9EBB-BE41B41AAC12Q28239154-9AAD6039-80A7-425C-8ED3-147DF76CD4D6Q33228198-7695D9DD-8801-4062-AC8B-F20814DE500BQ34267746-9650E1BB-D121-42CA-AB54-981AE1045750Q35914730-FC6121D8-6C6C-4852-AE33-943A5A805B95Q36057460-0AC52F0F-0DF1-4B13-B36E-E244A3D9E9E4Q36672598-0F5FD568-5186-41A6-A8F8-A985B56B9774Q36943620-3F077C13-C740-4350-BC6D-7F7518B49030Q37026629-710FD7B2-C0CB-455A-9605-265250E2F3A3Q37201291-E1118673-7F12-4483-B64D-1FFA3A6A18DBQ37514264-0B660C5C-1434-46FA-8756-093F155A6A44Q38134739-CF83F387-83C0-42CD-B55B-BF136E04D755Q42017315-AC3F930A-2C14-45FD-9972-7048AD86C1B9Q42639487-F566C6D2-CF6D-44D0-A21B-47A8707DE5C1Q43072124-1E0810AC-3521-47D5-97A4-A5D452227256Q45973150-8875DAAA-E117-43EC-BD78-79F8A464CC42Q46659792-3AEDEC02-A876-4143-B28B-B5A99E3D8AF3Q47195452-FE7C7317-BC66-4C33-8C34-2C612AEEC0AEQ50133590-AAC684F1-86F5-4197-BE1B-375074EAEC97
P2860
Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Yeast whole glucan particle (W ...... al antibodies to treat cancer.
@ast
Yeast whole glucan particle (W ...... al antibodies to treat cancer.
@en
type
label
Yeast whole glucan particle (W ...... al antibodies to treat cancer.
@ast
Yeast whole glucan particle (W ...... al antibodies to treat cancer.
@en
prefLabel
Yeast whole glucan particle (W ...... al antibodies to treat cancer.
@ast
Yeast whole glucan particle (W ...... al antibodies to treat cancer.
@en
P2093
P2860
P356
P1476
Yeast whole glucan particle (W ...... al antibodies to treat cancer.
@en
P2093
Brian Brandley
Daniel J Allendorf
P2860
P304
P356
10.1517/14712598.5.5.691
P407
P577
2005-05-01T00:00:00Z